Cytomegalovirus is one of the most important infections to occur after allogeneic
haematopoietic stem cell transplantation (HSCT), and an increasing number of reports …

The past 2 decades have seen a revolution in our approach to therapeutic
immunosuppression. We have moved from relying on broadly active traditional medications …

Host defense from infection depends upon a complex, integrated system of physical barriers
(eg, skin, stomach acid, and mucociliary clearance), innate immunity (eg, phagocytic cells …

CMV infection is associated with increased risk of IFD in posttransplant recipients because
of a number of overlapping and virus-specific risk factors. Better understanding of how CMV …

Cytomegalovirus (CMV) infection in clinical settings other than the allogeneic transplant
represents a poorly explored issue. Thus, we performed a comprehensive review of the …

Introduction The rapidly developed CAR-T cell therapy has a unique profile of side effects,
which perhaps has not been totally realized and understood, especially the late-phase …

BACKGROUND The combination of fludarabine, cyclophosphamide, and rituximab (FC‐R)
shows significant in vitro synergism and may improve patient outcome with little overlapping …

Cancer patients frequently suffer from gastrointestinal complications. In this manuscript, we
update our 2013 guideline on the diagnosis and management of gastrointestinal …

Viral infections are an underrecognized problem in children on standard chemotherapy for
acute lymphoblastic leukemia (ALL). In countries with high baseline seroprevalence of …

Background Although cytomegalovirus (CMV) is not considered tumorigenic, there is
evidence for its oncomodulatory effects and association with hematological neoplasms …